Go Pro

John Wiley & Sons (WLY) Financials

John Wiley & Sons logo
$47.09 -1.10 (-2.28%)
Closing price 06/29/2026 03:59 PM Eastern
Extended Trading
$47.74 +0.64 (+1.37%)
As of 08:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for John Wiley & Sons

Annual Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders
146 114 192 168 -74 148 148 17 -200 84 222
Consolidated Net Income / (Loss)
146 114 192 168 -74 148 148 17 -200 84 222
Net Income / (Loss) Continuing Operations
146 114 192 168 -74 148 148 17 -200 84 222
Total Pre-Tax Income
175 191 214 213 -63 176 210 33 -187 143 215
Total Operating Income
188 211 231 224 -54 186 219 56 52 221 277
Total Gross Profit
1,261 1,218 1,265 1,245 1,240 1,316 1,382 1,327 1,293 1,246 1,245
Total Revenue
1,727 1,719 1,796 1,800 1,831 1,942 2,083 2,020 1,873 1,678 1,677
Operating Revenue
1,727 1,719 1,796 1,800 1,831 1,942 2,083 2,020 1,873 1,678 1,677
Total Cost of Revenue
466 501 531 555 591 625 701 693 580 431 432
Operating Cost of Revenue
466 501 531 555 591 625 701 693 580 431 432
Total Operating Expenses
1,073 1,006 1,034 1,021 1,295 1,131 1,163 1,271 1,241 1,025 968
Selling, General & Admin Expense
994 943 953 964 997 1,023 1,080 1,037 1,014 947 896
Amortization Expense
50 50 48 55 62 75 85 85 56 52 53
Impairment Charge
- - 3.60 0.00 202 0.00 0.00 100 108 0.00 0.00
Restructuring Charge
29 13 29 3.12 33 33 -1.43 49 63 26 19
Total Other Income / (Expense), net
-13 -20 -18 -11 -8.81 -9.60 -9.62 -23 -239 -79 -62
Interest Expense
17 17 13 16 25 18 20 38 49 53 44
Other Income / (Expense), net
0.47 -3.42 -4.26 5.08 16 8.78 10 15 -190 -26 -18
Income Tax Expense
29 77 22 45 11 28 61 16 13 59 -6.53
Basic Earnings per Share
$2.51 $1.98 $3.37 $2.94 ($1.32) $2.65 $2.66 $0.31 ($3.65) $1.56 $4.22
Weighted Average Basic Shares Outstanding
58.00M 57.34M 57.04M 57.19M 56.21M 55.93M 55.76M 55.56M 54.95M 54.05M 52.47M
Diluted Earnings per Share
$2.48 $1.95 $3.32 $2.91 ($1.32) $2.63 $2.62 $0.31 ($3.65) $1.53 $4.16
Weighted Average Diluted Shares Outstanding
58.73M 58.20M 57.89M 57.84M 56.21M 56.46M 56.60M 56.36M 54.95M 54.83M 53.25M
Weighted Average Basic & Diluted Shares Outstanding
58.10M 57.40M 57M 57.20M 55.86M 55.85M 55.75M 55.28M 54.43M 53.39M 50.76M

Quarterly Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-19 -114 25 -1.44 40 -23 68 12 45 30 135
Consolidated Net Income / (Loss)
-19 -114 25 -1.44 40 -23 68 12 45 30 135
Net Income / (Loss) Continuing Operations
-19 -114 25 -1.44 40 -23 68 12 45 30 135
Total Pre-Tax Income
-22 -112 54 23 49 19 52 18 58 44 95
Total Operating Income
46 -46 69 29 64 52 76 31 73 63 110
Total Gross Profit
337 317 345 295 320 300 332 288 317 302 338
Total Revenue
493 461 468 404 427 405 443 397 422 410 448
Operating Revenue
493 461 468 404 427 405 443 397 422 410 448
Total Cost of Revenue
156 144 123 109 107 104 111 109 104 108 110
Operating Cost of Revenue
156 144 123 109 107 104 111 109 104 108 110
Total Operating Expenses
291 363 276 266 255 249 255 257 244 240 228
Selling, General & Admin Expense
252 253 252 249 239 230 230 240 225 219 211
Amortization Expense
14 14 13 13 13 13 13 13 13 13 13
Restructuring Charge
25 15 11 3.87 3.63 5.57 12 3.04 6.03 7.06 3.08
Total Other Income / (Expense), net
-68 -66 -15 -5.97 -15 -33 -24 -13 -15 -18 -15
Interest Expense
13 13 11 13 14 14 11 11 12 11 9.65
Other Income / (Expense), net
-55 -53 -3.37 6.82 -0.73 -19 -13 -2.21 -3.32 -6.71 -5.68
Income Tax Expense
-2.59 1.58 29 24 8.48 42 -16 6.01 13 15 -40
Basic Earnings per Share
($0.35) ($2.08) $0.45 ($0.03) $0.75 ($0.43) $1.27 $0.22 $0.85 $0.57 $2.58
Weighted Average Basic Shares Outstanding
55.10M 54.81M 54.95M 54.38M 54.19M 53.95M 54.05M 53.38M 53.09M 52.25M 52.47M
Diluted Earnings per Share
($0.35) ($2.08) $0.45 ($0.03) $0.74 ($0.43) $1.25 $0.22 $0.84 $0.56 $2.54
Weighted Average Diluted Shares Outstanding
55.10M 54.81M 54.95M 54.38M 54.85M 53.95M 54.83M 53.97M 53.52M 52.66M 53.25M
Weighted Average Basic & Diluted Shares Outstanding
54.87M 54.73M 54.43M 54.28M 54.03M 53.85M 53.39M 53.20M 52.56M 51.32M 50.76M

Annual Cash Flow Statements for John Wiley & Sons

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Net Change in Cash & Equivalents
-94 -305 108 -77 109 -109 6.37 6.54 -7.72 -14 -10
Net Cash From Operating Activities
350 315 382 251 288 360 339 277 208 203 261
Net Cash From Continuing Operating Activities
350 315 382 251 288 360 339 277 208 203 261
Net Income / (Loss) Continuing Operations
146 114 192 168 -74 148 148 17 -200 84 222
Consolidated Net Income / (Loss)
146 114 192 168 -74 148 148 17 -200 84 222
Depreciation Expense
66 67 64 69 77 91 95 96 98 79 74
Amortization Expense
199 205 206 92 98 109 120 118 80 70 72
Non-Cash Adjustments To Reconcile Net Income
58 95 34 21 270 111 80 185 398 125 29
Changes in Operating Assets and Liabilities, net
-119 -165 -114 -99 -83 -100 -104 -139 -169 -155 -136
Net Cash From Investing Activities
-151 -243 -177 -302 -347 -433 -194 -98 -107 -94 28
Net Cash From Continuing Investing Activities
-151 -243 -177 -302 -347 -433 -194 -98 -107 -94 28
Purchase of Property, Plant & Equipment
-86 -105 -114 -77 -89 -77 -89 -81 -76 -61 -51
Acquisitions
-20 -155 -27 -200 -231 -330 -82 8.29 -4.89 -11 112
Other Investing Activities, net
-45 -44 -37 -24 -27 -26 -27 -26 -26 -21 -33
Net Cash From Financing Activities
-286 -346 -97 -18 173 -47 -132 -169 -107 -125 -298
Net Cash From Continuing Financing Activities
-286 -346 -97 -18 173 -47 -132 -169 -107 -125 -298
Repayment of Debt
-613 -923 -472 -482 -635 -544 -668 -1,054 -1,161 -1,182 -1,081
Repurchase of Common Equity
-70 -50 -40 -60 -47 -16 -30 -35 -45 -60 -100
Payment of Dividends
-70 -72 -74 -76 -77 -77 -77 -77 -77 -76 -74
Issuance of Debt
467 683 459 596 934 593 651 1,005 1,185 1,200 965
Other Financing Activities, net
0.93 16 29 3.75 -3.79 -3.43 -7.11 -8.00 -8.50 -6.97 -7.99
Other Net Changes in Cash
- -31 - - -4.94 12 -7.07 -3.57 -1.49 3.15 -0.58
Cash Interest Paid
15 16 12 15 24 17 18 36 47 51 43
Cash Income Taxes Paid
39 34 49 48 42 41 49 51 51 54 58

Quarterly Cash Flow Statements for John Wiley & Sons

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Change in Cash & Equivalents
-7.64 9.29 -9.36 -10 -14 29 -19 -4.03 -14 28 -19
Net Cash From Operating Activities
-1.15 108 183 -89 -5.28 146 150 -85 8.50 180 157
Net Cash From Continuing Operating Activities
-1.15 108 183 -89 -5.28 146 150 -85 8.50 180 157
Net Income / (Loss) Continuing Operations
-19 -114 25 -1.44 40 -23 68 12 45 30 135
Consolidated Net Income / (Loss)
-19 -114 25 -1.44 40 -23 68 12 45 30 135
Depreciation Expense
20 27 29 20 20 19 20 19 19 18 18
Amortization Expense
20 18 18 17 17 17 18 17 17 17 20
Non-Cash Adjustments To Reconcile Net Income
74 153 60 15 25 38 48 20 23 34 -49
Changes in Operating Assets and Liabilities, net
-96 24 50 -139 -107 95 -3.63 -154 -96 81 33
Net Cash From Investing Activities
-26 -27 -28 -24 -21 -25 -24 99 -26 -27 -18
Net Cash From Continuing Investing Activities
-26 -27 -28 -24 -21 -25 -24 99 -26 -27 -18
Purchase of Property, Plant & Equipment
-20 -17 -19 -15 -15 -13 -19 -12 -13 -13 -13
Acquisitions
- -2.85 -10 -7.30 -1.73 -3.12 0.91 115 -1.04 -0.01 -2.18
Other Investing Activities, net
-6.51 -5.74 -0.40 -2.00 -4.42 -8.77 -6.11 -4.31 -12 -14 -2.14
Net Cash From Financing Activities
24 -74 -163 102 11 -89 -149 -17 3.95 -127 -158
Net Cash From Continuing Financing Activities
24 -74 -163 102 11 -89 -149 -17 3.95 -127 -158
Repayment of Debt
-182 -368 -409 -313 -312 -301 -256 -261 -175 -273 -372
Repurchase of Common Equity
-13 -6.50 -16 -13 -13 -10 -25 -14 -22 -35 -30
Payment of Dividends
-19 -19 -19 -19 -19 -19 -19 -19 -19 -19 -18
Issuance of Debt
238 320 285 450 356 241 153 281 220 199 265
Other Financing Activities, net
-0.28 -0.91 -2.99 -3.75 -0.22 -0.16 -2.84 -4.31 -0.02 -0.10 -3.56
Other Net Changes in Cash
-4.20 2.38 -1.93 0.80 0.64 -3.06 4.76 -0.96 -0.48 1.73 -0.87
Cash Interest Paid
12 13 11 12 14 14 11 11 11 11 9.93
Cash Income Taxes Paid
14 12 12 9.17 20 14 11 16 16 15 11

Annual Balance Sheets for John Wiley & Sons

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Total Assets
2,921 2,606 2,839 2,949 3,169 3,446 3,362 3,109 2,725 2,691 2,592
Total Current Assets
671 360 480 503 615 526 551 541 454 440 420
Cash & Equivalents
364 59 170 93 202 94 100 107 83 86 76
Accounts Receivable
168 189 212 307 309 312 332 310 224 228 244
Inventories, net
58 48 39 36 44 43 37 31 26 23 19
Prepaid Expenses
81 65 58 67 59 78 82 94 86 103 81
Plant, Property, & Equipment, net
215 243 290 289 298 282 272 247 192 162 136
Total Noncurrent Assets
2,036 2,003 2,070 2,157 2,256 2,638 2,539 2,320 2,079 2,089 2,036
Goodwill
952 982 1,020 1,096 1,117 1,304 1,302 1,204 1,091 1,122 1,132
Intangible Assets
877 828 848 866 807 1,015 931 855 616 595 579
Other Noncurrent Operating Assets
144 193 202 196 332 318 306 262 353 373 325
Total Liabilities & Shareholders' Equity
2,921 2,606 2,839 2,949 3,169 3,446 3,362 3,109 2,725 2,691 2,592
Total Liabilities
1,884 1,603 1,649 1,767 2,235 2,355 2,219 2,064 1,986 1,939 1,744
Total Current Liabilities
782 788 874 882 927 989 969 896 873 821 779
Short-Term Debt
- - - 0.00 9.38 13 19 5.00 7.50 10 13
Accounts Payable
166 76 90 91 94 96 77 84 56 61 67
Accrued Expenses
- 63 73 78 87 79 102 113 97 110 98
Current Employee Benefit Liabilities
103 104 116 97 108 145 117 80 97 93 71
Other Current Liabilities
76 86 581 595 615 657 116 612 578 547 530
Total Noncurrent Liabilities
1,102 815 775 885 1,308 1,366 1,250 1,312 1,112 1,118 965
Long-Term Debt
605 365 360 479 766 809 768 743 767 789 671
Noncurrent Deferred & Payable Income Tax Liabilities
190 160 144 144 119 173 180 288 97 105 99
Noncurrent Employee Benefit Liabilities
224 215 190 166 188 146 79 86 71 72 60
Other Noncurrent Operating Liabilities
83 75 81 96 235 238 223 195 166 152 135
Commitments & Contingencies
- - - - - - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,037 1,003 1,191 1,181 850 1,091 1,142 1,045 740 752 848
Total Preferred & Common Equity
1,037 1,003 1,191 1,181 934 1,091 1,142 1,045 740 752 848
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,037 1,003 1,191 1,181 850 1,091 1,139 1,045 740 752 848
Common Stock
452 471 490 505 432 528 542 553 558 565 570
Retained Earnings
1,673 1,715 1,834 1,931 1,780 1,850 1,921 1,861 1,583 1,591 1,738
Treasury Stock
-640 -676 -694 -746 -786 -796 -813 -840 - -925 -1,018
Accumulated Other Comprehensive Income / (Loss)
-448 -507 -440 -509 -575 -491 -512 -529 -528 -479 -442

Quarterly Balance Sheets for John Wiley & Sons

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 10/31/2022 1/31/2023 7/31/2023 10/31/2023 1/31/2024 7/31/2024 10/31/2024 1/31/2025 7/31/2025 10/31/2025 1/31/2026
Total Assets
3,128 3,150 2,926 2,779 2,707 2,652 2,609 2,600 2,524 2,467 2,561
Total Current Assets
483 531 478 426 384 393 370 395 420 381 411
Cash & Equivalents
118 126 75 83 93 83 76 105 82 67 95
Accounts Receivable
260 284 153 147 161 192 183 185 220 210 200
Inventories, net
34 33 30 30 28 26 27 25 22 21 19
Prepaid Expenses
70 88 80 59 69 87 85 80 96 83 97
Plant, Property, & Equipment, net
250 248 224 223 208 185 172 165 152 147 142
Total Noncurrent Assets
2,395 2,371 2,225 2,131 2,115 2,074 2,066 2,041 1,952 1,939 2,008
Goodwill
1,268 1,203 1,102 1,082 1,097 1,100 1,102 1,079 1,118 1,116 1,139
Intangible Assets
861 868 657 631 629 609 598 572 580 582 595
Other Noncurrent Operating Assets
267 299 224 216 370 365 366 389 253 241 275
Total Liabilities & Shareholders' Equity
3,128 3,150 2,926 2,779 2,707 2,652 2,609 2,600 2,524 2,467 2,561
Total Liabilities
2,051 2,123 1,989 1,912 1,959 1,938 1,854 1,915 1,791 1,727 1,811
Total Current Liabilities
635 761 706 610 712 689 561 717 649 540 692
Short-Term Debt
44 5.00 5.00 5.00 6.25 8.75 10 10 10 10 11
Accounts Payable
46 32 44 49 45 39 40 53 36 48 50
Accrued Expenses
102 154 99 106 151 105 119 156 113 126 177
Current Deferred Revenue
- 369 370 236 301 367 241 313 362 219 293
Current Employee Benefit Liabilities
84 81 52 83 78 49 61 74 45 53 70
Other Current Liabilities
358 119 86 90 97 96 90 110 84 85 91
Total Noncurrent Liabilities
1,416 1,362 1,283 1,302 1,247 1,250 1,292 1,197 1,142 1,186 1,119
Long-Term Debt
979 941 891 938 901 910 951 877 818 862 796
Noncurrent Deferred & Payable Income Tax Liabilities
157 145 110 94 95 97 99 95 104 103 107
Noncurrent Employee Benefit Liabilities
76 78 81 76 72 68 71 70 72 72 73
Other Noncurrent Operating Liabilities
205 199 185 180 169 169 171 156 148 149 143
Commitments & Contingencies
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,078 1,027 937 867 748 714 755 685 733 740 750
Total Preferred & Common Equity
1,078 1,027 937 867 748 714 755 685 733 740 750
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,078 1,027 937 867 748 714 755 685 733 740 750
Common Stock
548 553 548 554 557 556 562 566 563 568 573
Retained Earnings
1,903 1,812 1,749 1,710 1,577 1,563 1,584 1,542 1,584 1,610 1,621
Accumulated Other Comprehensive Income / (Loss)
-546 -506 -517 -542 -527 -524 -496 -519 -478 -481 -453
Other Equity Adjustments
- - - - - - - - - -957 -991

Annual Metrics And Ratios for John Wiley & Sons

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
DEI Shares Outstanding
- - - - - - - - - - 51,322,996.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 51,322,996.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 4.32
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.23% -0.49% 4.51% 0.22% 1.75% 6.01% 7.28% -3.03% -7.27% -10.43% -0.06%
EBITDA Growth
-9.92% 5.67% 3.87% -21.61% -64.89% 187.96% 12.71% -36.11% -86.29% 755.76% 17.91%
EBIT Growth
-21.25% 10.32% 9.20% 0.82% -116.65% 609.52% 18.10% -69.13% -294.85% 241.57% 32.50%
NOPAT Growth
-15.88% -19.85% 65.36% -14.88% -121.47% 511.43% -0.79% -81.24% 25.72% 256.50% 118.73%
Net Income Growth
-17.58% -22.05% 69.11% -12.45% -144.15% 299.57% 0.04% -88.38% -1,262.42% 142.01% 163.33%
EPS Growth
-16.50% -21.37% 70.26% -12.35% -145.36% 299.24% -0.38% -88.17% -1,277.42% 141.92% 171.90%
Operating Cash Flow Growth
-1.45% -10.02% 21.41% -34.39% 14.99% 24.78% -5.79% -18.29% -25.06% -2.43% 28.59%
Free Cash Flow Firm Growth
-3.62% -58.27% 44.84% -106.93% 343.28% -778.86% 192.81% 117.10% -17.94% -40.44% 224.15%
Invested Capital Growth
-5.15% 2.45% 5.43% 13.50% -3.90% 20.77% 0.54% -15.66% -14.41% 2.76% -0.66%
Revenue Q/Q Growth
-0.42% 1.05% 1.41% 0.78% -0.90% 3.28% 0.45% -0.96% -2.99% -1.52% 0.32%
EBITDA Q/Q Growth
-1.68% 4.88% 2.93% -23.10% -63.93% 389.00% 0.42% 14.86% -46.06% -3.30% 11.39%
EBIT Q/Q Growth
-6.15% 11.26% 7.87% 4.27% -117.84% 950.27% 0.93% 124.84% -28.67% -0.95% 18.77%
NOPAT Q/Q Growth
-7.49% 14.77% -0.02% 5.63% -124.01% 712.59% 3.90% 30.52% -20.76% 113.51% 30.99%
Net Income Q/Q Growth
-8.01% 12.31% 4.00% 5.77% -150.54% 390.03% 1.24% 316.36% -27.40% 103.62% 43.57%
EPS Q/Q Growth
-7.81% 12.72% 4.08% 5.82% -151.36% 392.22% 1.16% 282.35% -27.62% 109.59% 44.95%
Operating Cash Flow Q/Q Growth
10.19% -31.91% 38.31% 2.88% 0.30% 1.57% -6.73% 18.24% -16.18% -13.99% 2.71%
Free Cash Flow Firm Q/Q Growth
-4.78% -40.86% 1.69% 84.29% 200.96% -92.31% -6.12% 203.27% -23.59% -37.92% 32.10%
Invested Capital Q/Q Growth
-11.53% -6.11% -5.96% -7.60% -19.77% -5.90% -5.13% -16.44% -15.01% -0.15% -0.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
73.01% 70.86% 70.43% 69.18% 67.73% 67.79% 66.36% 65.71% 69.05% 74.29% 74.26%
EBITDA Margin
26.26% 27.89% 27.72% 21.68% 7.48% 20.32% 21.35% 14.07% 2.08% 20.48% 24.17%
Operating Margin
10.89% 12.31% 12.89% 12.44% -2.96% 9.56% 10.53% 2.77% 2.79% 13.20% 16.51%
EBIT Margin
10.92% 12.11% 12.65% 12.73% -2.08% 10.01% 11.02% 3.51% -7.37% 11.65% 15.44%
Profit (Net Income) Margin
8.44% 6.61% 10.70% 9.35% -4.06% 7.64% 7.12% 0.85% -10.70% 5.02% 13.22%
Tax Burden Percent
83.40% 59.46% 89.84% 79.01% 117.74% 84.28% 70.74% 52.06% 107.10% 58.90% 103.04%
Interest Burden Percent
92.69% 91.86% 94.16% 92.96% 165.45% 90.54% 91.37% 46.72% 135.50% 73.11% 83.07%
Effective Tax Rate
16.60% 40.54% 10.16% 20.99% 0.00% 15.72% 29.26% 47.94% 0.00% 41.10% -3.04%
Return on Invested Capital (ROIC)
11.95% 9.72% 15.46% 12.01% -2.47% 9.40% 8.50% 1.73% 2.56% 9.02% 19.53%
ROIC Less NNEP Spread (ROIC-NNEP)
7.79% 5.30% 9.12% 8.98% -9.44% 8.23% 7.54% -0.28% -41.39% 2.41% 9.89%
Return on Net Nonoperating Assets (RNNOA)
1.99% 1.42% 2.06% 2.18% -4.84% 5.87% 4.78% -0.15% -25.00% 2.26% 8.17%
Return on Equity (ROE)
13.94% 11.14% 17.52% 14.19% -7.31% 15.27% 13.28% 1.58% -22.45% 11.28% 27.69%
Cash Return on Invested Capital (CROIC)
17.23% 7.30% 10.17% -0.64% 1.50% -9.42% 7.97% 18.71% 18.08% 6.29% 20.19%
Operating Return on Assets (OROA)
6.37% 7.53% 8.34% 7.92% -1.25% 5.87% 6.74% 2.19% -4.73% 7.22% 9.80%
Return on Assets (ROA)
4.92% 4.11% 7.06% 5.81% -2.43% 4.48% 4.36% 0.53% -6.87% 3.11% 8.39%
Return on Common Equity (ROCE)
13.94% 11.14% 17.52% 14.19% -7.31% 15.27% 13.26% 1.57% -22.45% 11.28% 27.69%
Return on Equity Simple (ROE_SIMPLE)
14.06% 11.33% 16.14% 14.24% -7.96% 13.59% 12.98% 1.65% -27.08% 11.19% 0.00%
Net Operating Profit after Tax (NOPAT)
157 126 208 177 -38 156 155 29 37 130 285
NOPAT Margin
9.08% 7.32% 11.58% 9.83% -2.07% 8.05% 7.45% 1.44% 1.95% 7.77% 17.02%
Net Nonoperating Expense Percent (NNEP)
4.16% 4.42% 6.34% 3.03% 6.97% 1.17% 0.96% 2.00% 43.95% 6.61% 9.63%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 8.41% 18.62%
Cost of Revenue to Revenue
26.99% 29.14% 29.57% 30.82% 32.27% 32.21% 33.64% 34.29% 30.95% 25.71% 25.74%
SG&A Expenses to Revenue
57.58% 54.89% 53.07% 53.53% 54.46% 52.67% 51.83% 51.36% 54.11% 56.48% 53.44%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
62.11% 58.55% 57.55% 56.74% 70.69% 58.24% 55.83% 62.95% 66.26% 61.09% 57.75%
Earnings before Interest and Taxes (EBIT)
189 208 227 229 -38 194 229 71 -138 195 259
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
454 479 498 390 137 394 445 284 39 344 405
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.15 2.40 2.59 1.89 2.15 2.62 2.29 1.95 2.76 3.12 2.48
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.29 1.40 1.72 1.24 1.00 1.47 1.25 1.01 1.09 1.40 1.25
Price to Earnings (P/E)
15.30 21.21 16.07 13.24 0.00 19.28 17.61 118.30 0.00 27.92 9.48
Dividend Yield
3.11% 3.66% 2.38% 4.24% 4.17% 2.68% 2.94% 3.78% 3.76% 3.23% 3.47%
Earnings Yield
6.54% 4.71% 6.22% 7.55% 0.00% 5.19% 5.68% 0.85% 0.00% 3.58% 10.55%
Enterprise Value to Invested Capital (EV/IC)
1.93 2.07 2.37 1.67 1.60 1.97 1.80 1.74 2.07 2.09 1.86
Enterprise Value to Revenue (EV/Rev)
1.43 1.58 1.83 1.45 1.31 1.85 1.58 1.33 1.46 1.83 1.62
Enterprise Value to EBITDA (EV/EBITDA)
5.45 5.67 6.59 6.70 17.54 9.09 7.42 9.43 70.14 8.92 6.68
Enterprise Value to EBIT (EV/EBIT)
13.11 13.06 14.43 11.41 0.00 18.46 14.37 37.83 0.00 15.68 10.46
Enterprise Value to NOPAT (EV/NOPAT)
15.75 21.61 15.77 14.77 0.00 22.94 21.26 92.11 74.67 23.49 9.49
Enterprise Value to Operating Cash Flow (EV/OCF)
7.06 8.63 8.57 10.42 8.33 9.96 9.73 9.67 13.16 15.12 10.40
Enterprise Value to Free Cash Flow (EV/FCFF)
10.92 28.77 23.97 0.00 104.18 0.00 22.70 8.50 10.55 33.66 9.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.58 0.36 0.30 0.41 0.91 0.75 0.69 0.72 1.05 1.06 0.81
Long-Term Debt to Equity
0.58 0.36 0.30 0.41 0.90 0.74 0.67 0.71 1.04 1.05 0.79
Financial Leverage
0.26 0.27 0.23 0.24 0.51 0.71 0.63 0.54 0.60 0.94 0.83
Leverage Ratio
2.83 2.71 2.48 2.44 3.01 3.41 3.05 2.96 3.27 3.63 3.30
Compound Leverage Factor
2.63 2.49 2.34 2.27 4.98 3.08 2.79 1.38 4.43 2.65 2.74
Debt to Total Capital
36.84% 26.68% 23.22% 28.84% 47.68% 42.95% 40.79% 41.73% 51.15% 51.52% 44.62%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.58% 0.65% 0.97% 0.28% 0.50% 0.64% 0.82%
Long-Term Debt to Total Capital
36.84% 26.68% 23.22% 28.84% 47.10% 42.30% 39.82% 41.45% 50.66% 50.88% 43.80%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.16% 73.32% 76.78% 71.16% 52.32% 57.05% 59.02% 58.27% 48.85% 48.48% 55.38%
Debt to EBITDA
1.33 0.76 0.72 1.23 5.66 2.08 1.77 2.63 19.89 2.33 1.69
Net Debt to EBITDA
0.53 0.64 0.38 0.99 4.18 1.84 1.54 2.26 17.75 2.08 1.50
Long-Term Debt to EBITDA
1.33 0.76 0.72 1.23 5.59 2.05 1.73 2.62 19.70 2.30 1.66
Debt to NOPAT
3.86 2.90 1.73 2.71 -20.39 5.25 5.07 25.72 21.17 6.13 2.40
Net Debt to NOPAT
1.54 2.44 0.91 2.18 -15.07 4.66 4.43 22.05 18.90 5.47 2.13
Long-Term Debt to NOPAT
3.86 2.90 1.73 2.71 -20.15 5.18 4.95 25.54 20.97 6.05 2.35
Altman Z-Score
2.27 2.55 2.76 2.39 1.70 2.07 2.20 2.02 1.77 2.25 2.47
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.17% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.86 0.46 0.55 0.57 0.66 0.53 0.57 0.60 0.52 0.54 0.54
Quick Ratio
0.68 0.31 0.44 0.45 0.55 0.41 0.45 0.47 0.35 0.38 0.41
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
226 94 137 -9.48 23 -157 145 315 259 91 295
Operating Cash Flow to CapEx
405.05% 299.74% 334.71% 325.05% 325.57% 464.97% 396.76% 422.56% 272.92% 329.56% 509.16%
Free Cash Flow to Firm to Interest Expense
13.54 5.58 10.30 -0.59 0.92 -8.52 7.34 8.36 5.28 1.73 6.73
Operating Cash Flow to Interest Expense
20.95 18.59 28.80 15.56 11.56 19.58 17.12 7.34 4.24 3.86 5.94
Operating Cash Flow Less CapEx to Interest Expense
15.78 12.39 20.20 10.77 8.01 15.37 12.81 5.60 2.68 2.69 4.77
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.62 0.66 0.62 0.60 0.59 0.61 0.62 0.64 0.62 0.63
Accounts Receivable Turnover
10.97 9.65 8.96 6.94 5.95 6.25 6.47 6.29 7.01 7.41 7.10
Inventory Turnover
7.67 9.48 12.16 14.78 14.93 14.52 17.71 20.58 20.36 17.57 20.48
Fixed Asset Turnover
8.47 7.51 6.74 6.22 6.24 6.69 7.52 7.79 8.52 9.46 11.24
Accounts Payable Turnover
2.85 4.13 6.38 6.13 6.40 6.60 8.09 8.56 8.28 7.40 6.73
Days Sales Outstanding (DSO)
33.27 37.84 40.75 52.62 61.38 58.37 56.38 58.01 52.06 49.24 51.44
Days Inventory Outstanding (DIO)
47.59 38.49 30.02 24.70 24.45 25.14 20.61 17.74 17.93 20.77 17.82
Days Payable Outstanding (DPO)
128.28 88.39 57.20 59.57 57.02 55.30 45.12 42.63 44.07 49.33 54.20
Cash Conversion Cycle (CCC)
-47.43 -12.06 13.57 17.74 28.81 28.21 31.87 33.12 25.92 20.68 15.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,278 1,310 1,381 1,567 1,506 1,819 1,829 1,543 1,320 1,466 1,456
Invested Capital Turnover
1.32 1.33 1.34 1.22 1.19 1.17 1.14 1.20 1.31 1.16 1.15
Increase / (Decrease) in Invested Capital
-69 31 71 186 -61 313 9.82 -286 -222 39 -9.74
Enterprise Value (EV)
2,472 2,717 3,278 2,614 2,403 3,586 3,298 2,680 2,732 3,064 2,708
Market Capitalization
2,230 2,411 3,088 2,228 1,830 2,858 2,611 2,039 2,040 2,350 2,101
Book Value per Share
$17.97 $17.49 $20.74 $20.66 $15.17 $19.53 $20.44 $18.85 $13.51 $13.97 $16.53
Tangible Book Value per Share
($13.71) ($14.08) ($11.80) ($13.64) ($19.15) ($21.99) ($19.65) ($18.28) ($17.67) ($17.91) ($16.82)
Total Capital
1,642 1,368 1,551 1,660 1,625 1,913 1,929 1,793 1,514 1,552 1,532
Total Debt
605 365 360 479 775 822 787 748 775 799 683
Total Long-Term Debt
605 365 360 479 766 809 768 743 767 789 671
Net Debt
241 306 190 386 573 728 687 642 691 714 608
Capital Expenditures (CapEx)
86 105 114 77 89 77 85 66 76 61 51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-475 -487 -564 -473 -505 -544 -500 -456 -495 -457 -422
Debt-free Net Working Capital (DFNWC)
-111 -428 -394 -380 -303 -450 -400 -349 -412 -371 -347
Net Working Capital (NWC)
-111 -428 -394 -380 -312 -463 -419 -354 -419 -381 -359
Net Nonoperating Expense (NNE)
11 12 16 8.72 36 8.09 6.80 12 237 46 64
Net Nonoperating Obligations (NNO)
241 306 190 386 656 728 687 498 581 714 608
Total Depreciation and Amortization (D&A)
265 271 271 161 175 200 215 213 177 148 146
Debt-free, Cash-free Net Working Capital to Revenue
-27.50% -28.32% -31.41% -26.26% -27.60% -28.02% -24.01% -22.57% -26.43% -27.23% -25.20%
Debt-free Net Working Capital to Revenue
-6.43% -24.91% -21.96% -21.10% -16.54% -23.19% -19.19% -17.29% -21.98% -22.11% -20.68%
Net Working Capital to Revenue
-6.43% -24.91% -21.96% -21.10% -17.05% -23.83% -20.09% -17.54% -22.38% -22.71% -21.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.51 $1.98 $3.37 $2.94 ($1.32) $2.65 $2.66 $0.31 ($3.65) $1.56 $4.22
Adjusted Weighted Average Basic Shares Outstanding
58.00M 57.34M 57.04M 57.19M 56.21M 55.93M 55.76M 55.56M 54.95M 54.05M 52.47M
Adjusted Diluted Earnings per Share
$2.48 $1.95 $3.32 $2.91 ($1.32) $2.63 $2.62 $0.31 ($3.65) $1.53 $4.16
Adjusted Weighted Average Diluted Shares Outstanding
58.73M 58.20M 57.89M 57.84M 56.21M 56.46M 56.60M 56.36M 54.95M 54.83M 53.25M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $2.94 ($1.32) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
57.58M 57.20M 57.50M 56.63M 55.86M 55.85M 55.75M 55.28M 54.43M 53.39M 50.76M
Normalized Net Operating Profit after Tax (NOPAT)
181 134 237 179 126 184 154 107 157 145 207
Normalized NOPAT Margin
10.47% 7.78% 13.19% 9.97% 6.91% 9.50% 7.40% 5.29% 8.36% 8.67% 12.36%
Pre Tax Income Margin
10.12% 11.12% 11.91% 11.83% -3.44% 9.06% 10.07% 1.64% -9.99% 8.52% 12.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.29 12.28 17.12 14.21 -1.53 10.57 11.59 1.88 -2.82 3.72 5.91
NOPAT to Interest Expense
9.39 7.42 15.66 10.98 -1.52 8.50 7.83 0.77 0.75 2.48 6.51
EBIT Less CapEx to Interest Expense
6.12 6.08 8.51 9.42 -5.08 6.36 7.27 0.14 -4.37 2.55 4.74
NOPAT Less CapEx to Interest Expense
4.22 1.22 7.06 6.19 -5.07 4.29 3.52 -0.97 -0.81 1.31 5.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
47.95% 62.96% 38.27% 45.02% -103.19% 51.90% 52.06% 448.55% -38.42% 90.42% 33.55%
Augmented Payout Ratio
95.95% 107.24% 58.92% 80.67% -165.91% 62.53% 72.28% 651.65% -60.91% 162.22% 78.71%

Quarterly Metrics And Ratios for John Wiley & Sons

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
DEI Shares Outstanding
- - - - - - - - - 52,558,394.00 51,322,996.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 52,558,394.00 51,322,996.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.56 2.64
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.28% -6.24% -10.96% -10.47% -13.44% -12.17% -5.52% -1.74% -1.14% - 1.21%
EBITDA Growth
-71.77% -296.66% -22.73% 241.39% 222.12% 229.29% -11.33% -10.74% 5.48% - 40.91%
EBIT Growth
-115.77% -50.12% -31.98% 137.52% 797.24% 133.04% -2.87% -19.67% 9.91% - 64.41%
NOPAT Growth
-28.68% 30.79% -51.12% 84.20% 63.79% -96.12% 209.61% 1,231.15% 6.54% - 57.55%
Net Income Growth
-150.91% -59.33% -63.03% 98.44% 308.06% 79.84% 169.52% 914.76% 10.96% - 98.77%
EPS Growth
-151.47% -61.24% -63.71% 98.20% 311.43% 79.33% 177.78% 833.33% 13.51% - 103.20%
Operating Cash Flow Growth
-108.38% -16.99% -17.94% -7.75% -358.73% 35.61% -17.97% 4.18% 260.98% - 4.57%
Free Cash Flow Firm Growth
374.67% 647.87% -27.75% -128.88% -121.17% -91.62% -59.42% 186.38% 233.25% - 176.82%
Invested Capital Growth
-25.68% -15.85% -14.41% 9.14% 11.38% -5.50% 2.76% -6.03% -5.87% - -0.66%
Revenue Q/Q Growth
9.27% -6.51% 1.68% -13.80% 5.64% -5.15% 9.38% -10.34% 6.29% - 9.24%
EBITDA Q/Q Growth
160.16% -272.13% 311.26% -35.38% 37.07% -30.91% 46.44% -35.64% 61.99% - 55.76%
EBIT Q/Q Growth
90.47% -988.47% 166.09% -45.29% 77.14% -48.42% 94.30% -54.75% 142.37% - 86.38%
NOPAT Q/Q Growth
382.76% -200.36% 199.05% -105.62% 3,031.47% -220.17% 256.37% -79.47% 176.10% - 274.13%
Net Income Q/Q Growth
78.92% -485.63% 122.19% -105.68% 2,917.41% -156.74% 396.65% -82.82% 283.68% - 356.04%
EPS Q/Q Growth
79.04% -494.29% 121.63% -106.67% 2,566.67% -158.11% 390.70% -82.40% 281.82% - 353.57%
Operating Cash Flow Q/Q Growth
98.60% 9,469.07% 69.96% -148.40% 94.05% 2,869.73% 2.80% -156.54% 110.00% - -12.57%
Free Cash Flow Firm Q/Q Growth
16.96% -51.96% -2.17% -152.53% 14.26% 119.01% 176.35% 91.74% 32.26% - 251.00%
Invested Capital Q/Q Growth
2.11% 5.45% -15.01% 19.25% 4.21% -10.53% -0.15% 0.94% 4.39% - -0.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
68.42% 68.82% 73.67% 72.95% 74.92% 74.24% 74.93% 72.47% 75.25% - 75.43%
EBITDA Margin
6.31% -11.61% 24.13% 18.09% 23.47% 17.10% 22.89% 16.43% 25.04% - 31.87%
Operating Margin
9.38% -10.07% 14.68% 7.17% 15.03% 12.81% 17.28% 7.80% 17.31% - 24.59%
EBIT Margin
-1.85% -21.48% 13.96% 8.86% 14.86% 8.08% 14.36% 7.25% 16.52% - 23.32%
Profit (Net Income) Margin
-3.95% -24.72% 5.39% -0.36% 9.48% -5.67% 15.39% 2.95% 10.64% - 30.22%
Tax Burden Percent
88.27% 101.41% 46.79% -6.24% 82.67% -122.93% 130.28% 66.08% 77.38% - 142.51%
Interest Burden Percent
242.27% 113.46% 82.56% 64.27% 77.19% 57.10% 82.26% 61.59% 83.25% - 90.92%
Effective Tax Rate
0.00% 0.00% 53.21% 106.24% 17.33% 222.93% -30.28% 33.92% 22.62% - -42.51%
Return on Invested Capital (ROIC)
7.46% -8.01% 8.99% -0.54% 14.05% -17.76% 26.12% 5.64% 14.01% - 40.21%
ROIC Less NNEP Spread (ROIC-NNEP)
0.59% -18.03% 7.71% -0.49% 12.36% -12.62% 21.61% 4.55% 12.64% - 36.94%
Return on Net Nonoperating Assets (RNNOA)
0.46% -16.50% 4.65% -0.40% 11.36% -13.98% 20.28% 5.06% 14.28% - 30.50%
Return on Equity (ROE)
7.92% -24.51% 13.64% -0.95% 25.41% -31.74% 46.40% 10.70% 28.29% - 70.71%
Cash Return on Invested Capital (CROIC)
31.30% 19.93% 18.08% -4.21% -37.72% 9.70% 6.29% 16.57% 16.16% - 20.19%
Operating Return on Assets (OROA)
-1.23% -14.16% 8.97% 5.80% 9.71% 5.19% 8.89% 4.68% 10.84% - 14.80%
Return on Assets (ROA)
-2.62% -16.29% 3.46% -0.23% 6.19% -3.64% 9.53% 1.90% 6.99% - 19.18%
Return on Common Equity (ROCE)
7.92% -24.51% 13.64% -0.95% 25.41% -31.74% 46.40% 10.70% 28.29% - 70.71%
Return on Equity Simple (ROE_SIMPLE)
-13.24% -21.01% 0.00% -15.34% -6.57% 6.03% 0.00% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
32 -32 32 -1.81 53 -64 100 20 56 42 157
NOPAT Margin
6.57% -7.05% 6.87% -0.45% 12.43% -15.75% 22.51% 5.16% 13.39% - 35.04%
Net Nonoperating Expense Percent (NNEP)
6.86% 10.02% 1.28% -0.05% 1.68% -5.13% 4.50% 1.09% 1.37% - 3.27%
Return On Investment Capital (ROIC_SIMPLE)
- -1.96% - - - -4.05% 6.42% 1.31% 3.50% 2.69% 10.25%
Cost of Revenue to Revenue
31.58% 31.18% 26.33% 27.05% 25.08% 25.76% 25.07% 27.54% 24.75% - 24.57%
SG&A Expenses to Revenue
51.19% 55.00% 53.81% 61.62% 56.00% 56.83% 51.92% 60.57% 53.37% - 47.19%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue
59.04% 78.89% 58.99% 65.78% 59.88% 61.43% 57.65% 64.66% 57.94% - 50.80%
Earnings before Interest and Taxes (EBIT)
-9.09 -99 65 36 63 33 64 29 70 56 104
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
31 -54 113 73 100 69 101 65 106 92 143
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.86 2.40 2.76 3.64 3.54 3.23 3.12 2.81 2.65 - 2.48
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)
0.82 0.93 1.09 1.42 1.52 1.30 1.40 1.23 1.18 - 1.25
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 53.50 27.92 21.18 19.28 - 9.48
Dividend Yield
4.77% 4.26% 3.76% 2.94% 2.85% 3.44% 3.23% 3.66% 3.84% - 3.47%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 1.87% 3.58% 4.72% 5.19% - 10.55%
Enterprise Value to Invested Capital (EV/IC)
1.68 1.68 2.07 2.18 2.17 2.04 2.09 1.90 1.79 - 1.86
Enterprise Value to Revenue (EV/Rev)
1.26 1.35 1.46 1.88 2.02 1.76 1.83 1.68 1.66 - 1.62
Enterprise Value to EBITDA (EV/EBITDA)
22.05 36.18 70.14 20.99 15.31 8.43 8.92 8.36 8.10 - 6.68
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 54.27 15.18 15.68 14.90 14.21 - 10.46
Enterprise Value to NOPAT (EV/NOPAT)
78.00 56.58 74.67 50.28 0.00 49.02 23.49 17.77 17.17 - 9.49
Enterprise Value to Operating Cash Flow (EV/OCF)
9.17 10.54 13.16 17.07 18.07 12.71 15.12 13.61 12.57 - 10.40
Enterprise Value to Free Cash Flow (EV/FCFF)
4.57 7.71 10.55 0.00 0.00 20.43 33.66 11.10 10.75 - 9.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.09 1.21 1.05 1.29 1.27 1.29 1.06 1.13 1.18 - 0.81
Long-Term Debt to Equity
1.08 1.20 1.04 1.27 1.26 1.28 1.05 1.12 1.16 - 0.79
Financial Leverage
0.78 0.92 0.60 0.83 0.92 1.11 0.94 1.11 1.13 - 0.83
Leverage Ratio
3.04 3.30 3.27 3.38 3.32 3.70 3.63 3.58 3.39 - 3.30
Compound Leverage Factor
7.36 3.74 2.70 2.17 2.56 2.11 2.99 2.20 2.83 - 3.00
Debt to Total Capital
52.08% 54.79% 51.15% 56.28% 55.99% 56.42% 51.52% 53.05% 54.08% - 44.62%
Short-Term Debt to Total Capital
0.28% 0.38% 0.50% 0.54% 0.58% 0.64% 0.64% 0.64% 0.62% - 0.82%
Long-Term Debt to Total Capital
51.81% 54.41% 50.66% 55.74% 55.41% 55.79% 50.88% 52.41% 53.46% - 43.80%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
47.92% 45.21% 48.85% 43.72% 44.01% 43.58% 48.48% 46.95% 45.92% - 55.38%
Debt to EBITDA
8.40 12.56 19.89 5.61 4.13 2.50 2.33 2.47 2.55 - 1.69
Net Debt to EBITDA
7.66 11.27 17.75 5.11 3.81 2.20 2.08 2.22 2.36 - 1.50
Long-Term Debt to EBITDA
8.36 12.47 19.70 5.56 4.09 2.47 2.30 2.44 2.53 - 1.66
Debt to NOPAT
29.72 19.64 21.17 13.45 -2.29 14.52 6.13 5.24 5.41 - 2.40
Net Debt to NOPAT
27.10 17.63 18.90 12.24 -2.11 12.81 5.47 4.72 4.99 - 2.13
Long-Term Debt to NOPAT
29.56 19.51 20.97 13.32 -2.27 14.36 6.05 5.18 5.35 - 2.35
Altman Z-Score
1.98 1.81 2.01 2.23 2.38 2.07 2.09 2.16 2.29 - 2.28
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.70 0.54 0.52 0.57 0.66 0.55 0.54 0.65 0.71 - 0.54
Quick Ratio
0.38 0.36 0.35 0.40 0.46 0.40 0.38 0.47 0.51 - 0.41
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
541 260 254 -134 -115 22 60 115 153 47 167
Operating Cash Flow to CapEx
-5.69% 636.06% 974.67% -611.72% -36.34% 1,098.16% 786.06% -708.08% 64.79% - 1,192.59%
Free Cash Flow to Firm to Interest Expense
41.85 19.53 22.30 -10.45 -7.92 1.55 5.34 10.46 13.09 - 17.28
Operating Cash Flow to Interest Expense
-0.09 8.10 16.06 -6.94 -0.37 10.43 13.34 -7.70 0.73 - 16.30
Operating Cash Flow Less CapEx to Interest Expense
-1.65 6.82 14.41 -8.07 -1.37 9.48 11.64 -8.79 -0.40 - 14.93
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.66 0.66 0.64 0.65 0.65 0.64 0.62 0.65 0.66 - 0.63
Accounts Receivable Turnover
9.63 8.68 7.01 10.57 10.66 9.86 7.41 8.10 8.48 - 7.10
Inventory Turnover
20.47 20.49 20.36 18.95 16.89 16.53 17.57 18.05 17.69 - 20.48
Fixed Asset Turnover
8.30 8.46 8.52 8.94 8.91 9.14 9.46 9.90 10.44 - 11.24
Accounts Payable Turnover
13.95 16.30 8.28 12.92 10.87 9.04 7.40 11.50 9.74 - 6.73
Days Sales Outstanding (DSO)
37.90 42.03 52.06 34.54 34.25 37.03 49.24 45.06 43.02 - 51.44
Days Inventory Outstanding (DIO)
17.83 17.81 17.93 19.26 21.62 22.08 20.77 20.22 20.64 - 17.82
Days Payable Outstanding (DPO)
26.17 22.40 44.07 28.26 33.56 40.39 49.33 31.74 37.46 - 54.20
Cash Conversion Cycle (CCC)
29.56 37.45 25.92 25.54 22.31 18.72 20.68 33.54 26.20 - 15.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,473 1,553 1,320 1,574 1,641 1,468 1,466 1,479 1,544 1,462 1,456
Invested Capital Turnover
1.14 1.14 1.31 1.21 1.13 1.13 1.16 1.09 1.05 - 1.15
Increase / (Decrease) in Invested Capital
-509 -293 -222 132 168 -86 39 -95 -96 -5.54 -9.74
Enterprise Value (EV)
2,474 2,612 2,732 3,435 3,561 2,994 3,064 2,807 2,766 - 2,708
Market Capitalization
1,614 1,798 2,040 2,599 2,676 2,211 2,350 2,061 1,962 - 2,101
Book Value per Share
$15.71 $13.64 $13.51 $13.11 $13.91 $12.68 $13.97 $13.73 $13.91 $14.27 $16.53
Tangible Book Value per Share
($15.30) ($17.81) ($17.67) ($18.29) ($17.42) ($17.88) ($17.91) ($18.08) ($18.01) ($18.72) ($16.82)
Total Capital
1,810 1,655 1,514 1,632 1,716 1,572 1,552 1,561 1,612 1,558 1,532
Total Debt
943 907 775 919 961 887 799 828 872 808 683
Total Long-Term Debt
938 901 767 910 951 877 789 818 862 796 671
Net Debt
859 814 691 836 885 783 714 746 804 712 608
Capital Expenditures (CapEx)
20 17 19 15 15 13 19 12 13 13 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-263 -415 -495 -370 -257 -417 -457 -300 -217 -365 -422
Debt-free Net Working Capital (DFNWC)
-180 -322 -412 -287 -181 -312 -371 -219 -149 -270 -347
Net Working Capital (NWC)
-185 -328 -419 -296 -191 -322 -381 -229 -159 -281 -359
Net Nonoperating Expense (NNE)
52 81 6.91 -0.37 13 -41 32 8.76 12 12 22
Net Nonoperating Obligations (NNO)
606 805 581 861 885 783 714 746 804 712 608
Total Depreciation and Amortization (D&A)
40 45 48 37 37 36 38 36 36 36 38
Debt-free, Cash-free Net Working Capital to Revenue
-13.40% -21.49% -26.43% -20.25% -14.59% -24.48% -27.23% -17.98% -13.00% - -25.20%
Debt-free Net Working Capital to Revenue
-9.16% -16.67% -21.98% -15.73% -10.30% -18.34% -22.11% -13.08% -8.95% - -20.68%
Net Working Capital to Revenue
-9.42% -17.00% -22.38% -16.21% -10.86% -18.93% -22.71% -13.68% -9.55% - -21.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.35) ($2.08) $0.45 ($0.03) $0.75 ($0.43) $1.27 $0.22 $0.85 $0.57 $2.58
Adjusted Weighted Average Basic Shares Outstanding
55.10M 54.81M 54.95M 54.38M 54.19M 53.95M 54.05M 53.38M 53.09M 52.25M 52.47M
Adjusted Diluted Earnings per Share
($0.35) ($2.08) $0.45 ($0.03) $0.74 ($0.43) $1.25 $0.22 $0.84 $0.56 $2.54
Adjusted Weighted Average Diluted Shares Outstanding
55.10M 54.81M 54.95M 54.38M 54.85M 53.95M 54.83M 53.97M 53.52M 52.66M 53.25M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
54.87M 54.73M 54.43M 54.28M 54.03M 53.85M 53.39M 53.20M 52.56M 51.32M 50.76M
Normalized Net Operating Profit after Tax (NOPAT)
50 35 56 23 56 40 62 22 61 47 79
Normalized NOPAT Margin
10.13% 7.62% 11.92% 5.69% 13.13% 9.93% 14.07% 5.66% 14.50% - 17.69%
Pre Tax Income Margin
-4.47% -24.37% 11.53% 5.70% 11.47% 4.61% 11.81% 4.46% 13.75% - 21.20%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.70 -7.43 5.73 2.80 4.38 2.33 5.64 2.60 5.97 - 10.83
NOPAT to Interest Expense
2.50 -2.44 2.82 -0.14 3.67 -4.54 8.84 1.85 4.84 - 16.27
EBIT Less CapEx to Interest Expense
-2.27 -8.70 4.08 1.66 3.38 1.38 3.94 1.52 4.85 - 9.46
NOPAT Less CapEx to Interest Expense
0.94 -3.71 1.17 -1.28 2.66 -5.49 7.14 0.77 3.72 - 14.91
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-67.26% -49.03% -38.42% -70.11% -154.35% 184.69% 90.42% 78.01% 74.32% - 33.55%
Augmented Payout Ratio
-102.10% -74.47% -60.91% -113.54% -251.08% 309.22% 162.22% 141.14% 143.22% - 78.71%

Financials Breakdown Chart

Key Financial Trends

John Wiley & Sons (NYSE: WLY) has shown a meaningful turnaround in profitability and cash generation over the last year, but the balance sheet still carries a lot of leverage. Fiscal 2026 has started much better than fiscal 2025, with revenue stabilizing, margins improving, and operating cash flow rebounding sharply. At the same time, debt remains elevated and quarterly cash balances have been volatile, so the story is improving but not risk-free.

  • Profitability has improved dramatically year over year. In Q4 2026, WLY posted net income of $135.3 million versus a loss of $22.9 million in Q3 2025 and a loss of $113.9 million in Q3 2024. That is a clear swing back into profitability.
  • Operating income recovered strongly. Q4 2026 operating income was $110.1 million, up from $62.8 million in Q3 2026 and far better than the weak periods in fiscal 2025 and 2024.
  • Revenue has been relatively steady in the $400 million-plus range. Quarterly revenue moved from $396.8 million in Q1 2026 to $447.9 million in Q4 2026, suggesting the top line is not collapsing despite broader turbulence in prior periods.
  • Operating cash flow rebounded sharply. Q4 2026 operating cash flow was $157.2 million, a big improvement from $8.5 million in Q2 2026 and negative $85.0 million in Q1 2026.
  • Cash generation appears to be improving relative to earnings quality. WLY’s Q4 2026 net income of $135.3 million converted into strong operating cash flow, which is a favorable sign for earnings quality.
  • Equity value has held up. Common equity increased to $750.0 million in Q3 2026 from $685.2 million in Q3 2025, helped by the improvement in retained earnings.
  • Share dilution has been limited. Diluted shares were 53.2 million in Q4 2026, only modestly above 52.6 million in Q3 2026 and still in line with the recent trend.
  • Gross margins are fairly stable but not expanding dramatically. Q4 2026 gross profit was $337.9 million on $447.9 million of revenue, compared with $302.3 million on $410.0 million in Q3 2026. Revenue is improving, but margins are not showing a major structural breakout.
  • The company still relies on acquisitions and restructuring adjustments. Restructuring charges and acquisition-related cash flows continue to show up across the periods, which suggests ongoing portfolio reshaping.
  • Balance sheet composition remains dominated by intangible assets and goodwill. At Q3 2026, goodwill was $1.14 billion and intangible assets were $595.1 million, so a large portion of assets is not tangible.
  • Debt is still very high. As of Q3 2026, WLY had $11.3 million of short-term debt and $796.3 million of long-term debt, while Q2 2026 showed $861.7 million of long-term debt. Leverage remains a major risk factor.
  • Current liabilities exceed current assets by a wide margin. Q3 2026 current assets were $411.3 million versus current liabilities of $692.4 million, indicating weak near-term liquidity coverage.
  • Free cash flow is pressured by financing needs and capital spending. Even with stronger operating cash flow in Q4 2026, WLY still spent on capex, acquisitions, dividends, and debt service, which can limit flexibility.
  • Cash balances have been volatile quarter to quarter. Cash and equivalents fell to $67.4 million in Q2 2026 from $81.9 million in Q1 2026, then rose to $95.1 million in Q3 2026. That inconsistency reinforces the liquidity risk profile.
  • Interest expense remains meaningful. Q4 2026 interest expense was $9.6 million, and interest costs have stayed elevated across the periods, pressuring pre-tax earnings.

Bottom line: WLY’s recent results point to a business that is regaining traction, especially on profitability and operating cash flow. However, the company is still carrying a heavy debt load and modest liquidity cushion, so the stock likely remains more suitable for investors who are comfortable with financial leverage and execution risk.

06/30/26 06:57 AM ETAI Generated. May Contain Errors.

John Wiley & Sons Financials - Frequently Asked Questions

According to the most recent income statement we have on file, John Wiley & Sons' financial year ends in April. Their financial year 2026 ended on April 30, 2026.

John Wiley & Sons' net income appears to be on a downward trend, with a most recent value of $221.62 million in 2026, rising from $145.78 million in 2016. The previous period was $84.16 million in 2025. See John Wiley & Sons' forecast for analyst expectations on what's next for the company.

John Wiley & Sons' total operating income in 2026 was $276.86 million, based on the following breakdown:
  • Total Gross Profit: $1.25 billion
  • Total Operating Expenses: $968.16 million

Over the last 10 years, John Wiley & Sons' total revenue changed from $1.73 billion in 2016 to $1.68 billion in 2026, a change of -2.9%.

John Wiley & Sons' total liabilities were at $1.74 billion at the end of 2026, a 10.1% decrease from 2025, and a 7.5% decrease since 2016.

In the past 10 years, John Wiley & Sons' cash and equivalents has ranged from $58.52 million in 2017 to $363.81 million in 2016, and is currently $75.62 million as of their latest financial filing in 2026.

Over the last 10 years, John Wiley & Sons' book value per share changed from 17.97 in 2016 to 16.53 in 2026, a change of -8.0%.



Financial statements for NYSE:WLY last updated on 6/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners